1. Home
  2. QURE vs CLFD Comparison

QURE vs CLFD Comparison

Compare QURE & CLFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QURE
  • CLFD
  • Stock Information
  • Founded
  • QURE 1998
  • CLFD 1979
  • Country
  • QURE Netherlands
  • CLFD United States
  • Employees
  • QURE N/A
  • CLFD N/A
  • Industry
  • QURE Biotechnology: Pharmaceutical Preparations
  • CLFD Telecommunications Equipment
  • Sector
  • QURE Health Care
  • CLFD Utilities
  • Exchange
  • QURE Nasdaq
  • CLFD Nasdaq
  • Market Cap
  • QURE 725.4M
  • CLFD 595.3M
  • IPO Year
  • QURE 2007
  • CLFD N/A
  • Fundamental
  • Price
  • QURE $15.21
  • CLFD $44.00
  • Analyst Decision
  • QURE Strong Buy
  • CLFD Strong Buy
  • Analyst Count
  • QURE 10
  • CLFD 3
  • Target Price
  • QURE $37.20
  • CLFD $46.67
  • AVG Volume (30 Days)
  • QURE 1.0M
  • CLFD 122.5K
  • Earning Date
  • QURE 07-29-2025
  • CLFD 07-31-2025
  • Dividend Yield
  • QURE N/A
  • CLFD N/A
  • EPS Growth
  • QURE N/A
  • CLFD N/A
  • EPS
  • QURE N/A
  • CLFD N/A
  • Revenue
  • QURE $20,201,000.00
  • CLFD $178,209,000.00
  • Revenue This Year
  • QURE N/A
  • CLFD $10.77
  • Revenue Next Year
  • QURE $278.91
  • CLFD $14.46
  • P/E Ratio
  • QURE N/A
  • CLFD N/A
  • Revenue Growth
  • QURE 6.30
  • CLFD N/A
  • 52 Week Low
  • QURE $4.45
  • CLFD $23.78
  • 52 Week High
  • QURE $19.18
  • CLFD $46.76
  • Technical
  • Relative Strength Index (RSI)
  • QURE 55.32
  • CLFD 60.96
  • Support Level
  • QURE $13.61
  • CLFD $42.16
  • Resistance Level
  • QURE $15.49
  • CLFD $46.76
  • Average True Range (ATR)
  • QURE 0.81
  • CLFD 1.46
  • MACD
  • QURE 0.08
  • CLFD -0.03
  • Stochastic Oscillator
  • QURE 72.65
  • CLFD 58.74

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

About CLFD Clearfield Inc.

Clearfield Inc mainly designs, manufactures, and distributes fiber protection, fiber management and fiber delivery solutions for communications networks. It provides a various products including copper assemblies, cassettes, box enclosures, fiber connectors, frames, microduct, terminals, vaults, pedestal inserts, FieldSmart, WaveSmart, and CraftSmart. The company has international presence with the majority of the revenue derived from the United States. The company has two reportable segments namely Clearfield segment and Nestor cables segment. The majority of revenue is derived from Clearfield segment.

Share on Social Networks: